Endothelial dysfunction in postmenopausal women and hypertension

Women's Health

Volumn 3, Issue 5, 2007, Pages 515-518

  Nuzzo, Annachiara ^a   Rossi, Rosario ^a   Modena, Maria Grazia ^a  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; NITRIC OXIDE;

ANTIHYPERTENSIVE ACTIVITY; ATHEROGENESIS; ATHEROSCLEROSIS; BLOOD FLOWMETRY; BLOOD PRESSURE REGULATION; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL EFFECTIVENESS; CORONARY ARTERY DISEASE; DISEASE ASSOCIATION; DISEASE MARKER; EDITORIAL; ENDOTHELIAL DYSFUNCTION; HUMAN; HYPERTENSION; INSULIN RESISTANCE; MENOPAUSE; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; OXIDATIVE STRESS; PERIPHERAL VASCULAR DISEASE; POSTMENOPAUSE; RISK FACTOR; THROMBOSIS PREVENTION; VASCULAR ENDOTHELIUM; VASODILATATION;

EID: 35848932795     PISSN: 17455057     EISSN: 17455065     Source Type: Journal    
DOI: 10.2217/17455057.3.5.515     Document Type: Editorial

References (16)

1. Lerman A, Burnett JC Jr: Intact and altered endothelium in regulation of vasomotion. Circulation 86 (Suppl. 6), III12-III19 (1992).
2. Anderson TJ: Assessment and treatment of endothelial dysfunction in humans. J. Am. Coll. Cardiol. 34, 631-638 (1999).
3. Bonetti OP. Lerman LO, Lerman A: Endothelial dysfunction. A marker of atherosclerotic risk. Arterioscler. Thromb. Vasc. Biol. 23, 168-175 (2003).
4. Anderson TJ, Elstein E, Haber H, Charbornneau F: Comparative study of ACE-inhibition, angiotensin II antagonism, and calcium channel blockade on flow-mediated vasodilation in patients with coronary disease (BANFF study). J. Am. Coll. Cardiol. 35, 60-66 (2000).
5. Anderson TJ, Gerhard MD, Meredith IT et al.: Systemic nature of endothelial dysfunction in atherosclerosis. Am. J. Cardiol. 75, 71B-74B (1995).
6. Celermajer DS, Sorensen KE, Spiegelhalter DJ et al.: Aging is associated with endothelial dysfunction in healthy men years before the age-related decline in women. J. Am. Coll. Cardiol. 24, 471-476 (1994).
7. Panza JA, Quyyumi AA, Brush JE, Epstein SE: Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension. N. Engl. J. Med. 323, 22-27 (1990).
8. Celermajer DS, Sorensen KE, Georgakopoulos D et al.: Cigarette smoking is associated with dose-related and potentially reversibile impairment of endothelium-dependent dilation in healthy young adults. Circulation 88, 2149-2155 (1993).
9. Johnstone M, Creager SJ, Scales K, Cusco JA, Lee B, Creager MA: Impaired endothellum-dependent vasodilation in patients with insulin-dependent diabetes mellitus. Circulation 88, 2510-2516 (1993).
10. Rossi R, Molinari R, Aveta P, Muia N, Modena MG: Effects of single drug antihypertensive therapy on endothelium-dependent vasodilation in hypertensive postmenopausal women J. Am. Coll. Cardiol. 35(Suppl. A), A287 (2000).
11. Rossi R, Chiurlia E, Nuzzo A, Ciont E, Origliani G, Modena MG: Flow-mediated vasodilation and the risk of developing hypertension in healthy postmenopausal women. J. Am. Coll. Cardiol. 44, 1636-1640 (2004).
12. Rossi R, Cioni E, Nuzzo A, Crigliani G, Modena MG: Endothelial-dependent vasodilation and incidence of Type 2 diabetes in a population of healthy postmenopausal women. Diabetes Care 28, 702-707 (2005).
13. Rossi R, Turco V, Origliani G, Grazia MG: Type 2 diabetes mellitus is a risk factor for the development of hypertension in postmenopausal women. J. Hypertens. 24(10), 2617-2022 (2006).
14. Modena MG, Bonetti L, Coppi F, Burst F, Rossi R: Prognostic role of reversible endothelial dysfunction in hypertensive postmenopausal women. J. Am. Coll. Cardiol. 40, 505-510 (2002).
15. Lerman A, Zeiher AM: Endothelial function: cardiac events. Circulation 111, 363-368 (2005).
16. Ganz P, Vita JA: Testing endothelial vasomotor function. Nitric oxide, a multipotent molecule. Circulation 108, 2049-2053 (2003).